Current Protein Identity:P55263 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1BX4 STRUCTURE OF HUMAN ADENOSINE KINASE AT 1.50 ANGSTROMS Deposited 1998-10-13 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–345(345 aa)
Not recorded CL CHLORIDE ION × 2 MG MAGNESIUM ION × 3 ADN ADENOSINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 7.5;20%PEG 4K, 0.16M MGCL2, 0.1M TRIS, PH 7.5
Resolution 1.50 Å R-free 0.226
4O1L Human Adenosine Kinase in complex with inhibitor Deposited 2013-12-16 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 17–362(346 aa) Fragment:UNP residues 17-362
Chain B 17–362(346 aa) Fragment:UNP residues 17-362
Not recorded MG MAGNESIUM ION × 4 HO4 5-ethynyl-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine × 3 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å R-free 0.263
4O1L Human Adenosine Kinase in complex with inhibitor Deposited 2013-12-16 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 17–362(346 aa) Fragment:UNP residues 17-362
Not recorded MG MAGNESIUM ION × 2 HO4 5-ethynyl-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine × 2 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å R-free 0.263
4O1L Human Adenosine Kinase in complex with inhibitor Deposited 2013-12-16 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 17–362(346 aa) Fragment:UNP residues 17-362
Not recorded MG MAGNESIUM ION × 2 HO4 5-ethynyl-7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine × 1 X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 2.50 Å R-free 0.263
9O7P Crystal structure of human adenosine kinase (ADK) in complex with inhibitor BKI-1817 Deposited 2025-04-15 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–345(345 aa)
Not recorded CL CHLORIDE ION × 3 SO4 SULFATE ION × 15 A1B96 (6M)-6-{4-amino-1-[(1-methylpiperidin-4-yl)methyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}quinolin-2(1H)-one × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;2.4M ammonium sulfate, 0.1M Citrate pH 4.0. HosaA.19365.a.VZ21.PC00201 at 18 mg/mL. Cocrystallization with 2mM inhibitor. plate 14484 A12 drop 2, Puck: PSL1601, Cryo: 2.5M lithium sulfate
Resolution 2.51 Å R-free 0.246
9O7Q Crystal structure of human adenosine kinase (ADK) in complex with inhibitor BKI-1676 Deposited 2025-04-15 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–345(345 aa)
Not recorded A1B95 1-[(3P)-3-[6-(cyclopropyloxy)naphthalen-2-yl]-4-(methylamino)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropan-2-ol × 1 SO4 SULFATE ION × 13 CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;2.4M ammonium sulfate, 0.1M Citrate pH 4.0. HosaA.19365.a.VZ21.PC00201 at 18 mg/mL. Cocrystallization with 2mM inhibitor. plate 14484 A12/A8 drop 2, Puck: PSL1512, Cryo: 2.5M lithium sulfate
Resolution 2.81 Å R-free 0.265
9O7R Crystal structure of human adenosine kinase (ADK) in complex with inhibitor BKI-1553 Deposited 2025-04-15 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1–345(345 aa)
Not recorded CL CHLORIDE ION × 5 UW5 1-{4-amino-3-[6-(cyclopropyloxy)naphthalen-2-yl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}-2-methylpropan-2-ol × 1 SO4 SULFATE ION × 14 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 4;291 K;2.4M ammonium sulfate, 0.1M Citrate pH 4.0. HosaA.19365.a.VZ21.PC00201 at 18 mg/mL. Cocrystallization with 2mM inhibitor. plate 14484 A12 drop 2, Puck: PSL1502, Cryo: 2.5M lithium sulfate
Resolution 2.41 Å R-free 0.258